TURNOVER (x1000 DKK)
NET PROFIT (x1000 DKK)
EMPLOYEES
Bio Vitos Pharma AB
Closing information (x1000 DKK)
| Closing information | 2022/12 | 2021/12 | 2020/12 |
| Turnover |
882
|
815
|
228 |
| Financial expenses |
0
|
1
|
24 |
| Earnings before taxes |
-9,957
|
-10,146
|
-8,670 |
| EBITDA |
-5,196
|
-5,478
|
-4,465 |
| Total assets |
17,675
|
25,811
|
26,520 |
| Current assets |
3,490
|
8,070
|
6,146 |
| Current liabilities |
1,020
|
1,427
|
1,674 |
| Equity capital |
16,654
|
24,384
|
24,847 |
| - share capital |
2,067
|
1,262
|
725 |
| Employees (average) |
5
|
6
|
5 |
Financial ratios
| Fiscal year | 2022/12 | 2021/12 | 2020/12 |
| Solvency |
94.2%
|
94.5%
|
93.7% |
| Turnover per employee |
176
|
136
|
46 |
| Profit as a percentage of turnover |
-1128.9%
|
-1244.9%
|
-3802.6% |
| Return on assets (ROA) |
-56.3%
|
-39.3%
|
-32.6% |
| Current ratio |
342.2%
|
565.5%
|
367.1% |
| Return on equity (ROE) |
-59.8%
|
-41.6%
|
-34.9% |
| Change turnover |
133
|
592
|
228 |
| Change turnover % |
18%
|
265% | |
| Chg. No. of employees |
-1
|
1
|
-2 |
| Chg. No. of employees % |
-17%
|
20%
|
-29% |
Total value of public sale
| Fiscal year | 2022/12 | 2021/12 | 2020/12 |
| Total value of public sale |
0
|
0
|
0 |
Closing figures are converted to the currency above at the exchange rate of the closing date. Source for the exchange rates: Sveriges Riksbank
The closing information is gathered directly from the companies or from Creditsafe.